Articles
-
Anticipating Success: Meeting The Inherent Challenges Of Complex Drug Substances
9/17/2013
Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages.
-
DSM Pharmaceutical Products Brochure
4/30/2013
At DSM, our goal is to help you achieve your objectives both for today and the future. Consequently, we help you rapidly bring life-saving and life-enhancing medicines to
the people who need them. -
Kemwell Overview
3/29/2012
Manufacturing customers include top pharmaceutical companies – Allergan, Bayer, GSK, J&J, Pfizer, Teva, and Novartis, as well as small emerging biotech.
-
Kemwell Biopharma Brochure
3/29/2012
Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation and fill and finish at the cGMP manufacturing facility in Bangalore, India as a one-stop-shop through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by a preferred access to the large-scale commercial production of Boehringer Ingelheim at its facilities in Europe.
-
Sterile Clinical Trial Material Formulation & Filling
3/26/2012
DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
-
Cytotoxic Formulation & Filling
3/26/2012
DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
-
Brochure: Finished Dosage Forms
2/21/2012
DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
-
Brochure: Pharma Sterile Dosage Forms
1/30/2012
DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields.
-
Executive Insights Into CMO Selection: Greg Troiano, BIND Biosciences
11/11/2011
Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent — to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. By Rob Wright